American Journal of Cardiovascular Drugs

American Journal of Cardiovascular Drugs
期刊缩写:
AM J CARDIOVASC DRUG
影响因子:
2.8
ISSN:
print: 1175-3277
on-line: 1179-187X
研究领域:
医学-心血管系统
创刊年份:
2001年
h-index:
46
自引率:
3.30%
Gold OA文章占比:
29.66%
原创研究文献占比:
61.54%
SCI收录类型:
Science Citation Index Expanded (SCIE) || Scopus (CiteScore)
期刊介绍英文:
Promoting rational therapy within the discipline of cardiology, the American Journal of Cardiovascular Drugs covers all aspects of the treatment of cardiovascular disorders, particularly the place in therapy of newer and established agents. Via a program of reviews and original clinical research articles, the journal addresses major issues relating to treatment of these disorders, including the pharmacology, efficacy and adverse effects of the major classes of drugs; information on newly developed drugs and drug classes; the therapeutic implications of latest research into the aetiology of cardiovascular disorders; and the practical management of specific clinical situations. The American Journal of Cardiovascular Drugs offers a range of additional enhanced features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist patients, caregivers and others in understanding important medical advances. The journal also provides the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.
CiteScore:
CiteScoreSJRSNIPCiteScore排名
6.70.7900.784
学科
排名
百分位
大类:Medicine
小类:Cardiology and Cardiovascular Medicine
74 / 387
81%
大类:Medicine
小类:Pharmacology (medical)
63 / 272
77%
发文信息
中科院SCI期刊分区
大类 小类 TOP期刊 综述期刊
4区 医学
4区 心脏和心血管系统 CARDIAC & CARDIOVASCULAR SYSTEMS
4区 药学 PHARMACOLOGY & PHARMACY
WOS期刊分区
学科分类
Q2CARDIAC & CARDIOVASCULAR SYSTEMS
Q2PHARMACOLOGY & PHARMACY
历年影响因子
2015年2.2330
2016年2.7680
2017年2.6430
2018年2.5780
2019年2.6740
2020年3.5710
2021年3.2830
2022年3.0000
2023年2.8000
历年发表
2012年72
2013年57
2014年46
2015年55
2016年54
2017年47
2018年54
2019年77
2020年65
2021年59
2022年38
投稿信息
出版周期:
Bimonthly
出版语言:
English
出版国家(地区):
NEW ZEALAND
初审时长:
14 days
审稿时长:
>12 weeks
出版商:
Springer International Publishing
编辑部地址:
ADIS INT LTD, 41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND, NEW ZEALAND, 1311

American Journal of Cardiovascular Drugs - 最新文献

Intravenous Diltiazem Versus Metoprolol in Acute Rate Control of Atrial Fibrillation/Flutter and Rapid Ventricular Response: A Meta-Analysis of Randomized and Observational Studies

Pub Date : 2023-10-19 DOI: 10.1007/s40256-023-00615-3 Alexander Bolton, Bishow Paudel, Mehul Adhaduk, Mohammed Alsuhaibani, Riley Samuelson, Marin L. Schweizer, Denice Hodgson-Zingman

Safety and Effectiveness of Apixaban Versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation Stratified by Renal Function: A Retrospective Cohort Study

Pub Date : 2023-10-17 DOI: 10.1007/s40256-023-00611-7 Takeshi Morimoto, Haruhiko Hoshino, Yukako Matsuo, Tatsuki Ibuki, Kayoko Miyata, Yukihiro Koretsune

Cardioprotective Strategies After Ischemia–Reperfusion Injury

Pub Date : 2023-10-10 DOI: 10.1007/s40256-023-00614-4 Honghong Zhang, Huilin Hu, Changlin Zhai, Lele Jing, Hongen Tian
查看全部
免责声明:
本页显示期刊或杂志信息,仅供参考学习,不是任何期刊杂志官网,不涉及出版事务,特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题,请联系我们,邮箱:info@booksci.cn,我们会认真核实处理。
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信